Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Entrada Therapeutics, Inc. (TRDA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 31,211,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Entrada Therapeutics is an intracellular therapeutics company. Endosomal Escape Vehicle (EEV) therapeutics are comprised of small cyclic peptides that are chemically conjugated to a range of specific and active biological therapeutics. Co.'s EEV therapeutics are designed to engage intracellular targets that have long been considered inaccessible and undruggable. Through its proprietary modular EEV platform, Co. is building a development portfolio of EEV therapeutic candidates designed to enable the intracellular delivery of therapeutics in various organs and tissues with an improved therapeutic index. Co. is focused on the development of EEV therapeutics for rare neuromuscular diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 15,892 15,892 15,892 177,292
Total Buy Value $213,962 $213,962 $213,962 $1,187,869
Total People Bought 1 1 1 2
Total Buy Transactions 8 8 8 16
Total Shares Sold 6,912 22,412 123,393 295,774
Total Sell Value $87,784 $329,850 $1,946,898 $4,759,691
Total People Sold 3 3 5 5
Total Sell Transactions 3 9 27 93
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 213
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kim Peter S Director   –       •      –    2024-04-08 4 B $13.57 $35,290 D/D 2,600 62,936 2.39     -
   Kim Peter S Director   –       •      –    2024-03-28 4 B $13.75 $20,794 D/D 1,512 60,336 2.39     -
   Kim Peter S Director   –       •      –    2024-03-26 4 B $13.64 $37,509 D/D 2,750 58,824 2.39     -
   Kim Peter S Director   –       •      –    2024-03-25 4 B $13.36 $42,472 D/D 3,180 56,074 2.39     -
   Kim Peter S Director   –       •      –    2024-03-22 4 B $13.76 $42,901 D/D 3,118 52,894 2.39     -
   Kim Peter S Director   –       •      –    2024-03-21 4 B $13.24 $9,318 D/D 704 49,776 2.39     -
   Kim Peter S Director   –       •      –    2024-03-20 4 B $12.66 $14,281 D/D 1,128 49,072 2.39     -
   Kim Peter S Director   –       •      –    2024-03-19 4 B $12.66 $11,397 D/D 900 47,944 2.39     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2024-03-15 4 OE $2.10 $18,900 D/D 9,000 83,170     -
   Dowden Nathan J President & COO   •       –      –    2024-03-06 4 AS $12.32 $22,499 D/D (1,826) 137,204     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2024-03-06 4 AS $12.31 $50,285 D/D (4,086) 74,170     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2024-03-05 4 D $12.28 $18,062 D/D (1,471) 78,256     -
   Sethuraman Natarajan Chief Scientific Officer   •       –      –    2024-03-05 4 D $12.28 $18,480 D/D (1,505) 209,032     -
   Doshi Dipal CEO   •       •      –    2024-03-05 4 D $12.28 $61,996 D/D (5,049) 340,375     -
   Dowden Nathan J President & COO   •       –      –    2024-03-05 4 D $12.28 $18,246 D/D (1,486) 139,030     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2024-03-04 4 D $12.42 $9,625 D/D (744) 79,727     -
   Sethuraman Natarajan Chief Scientific Officer   •       –      –    2024-03-04 4 D $12.42 $9,845 D/D (761) 210,537     -
   Doshi Dipal CEO   •       •      –    2024-03-04 4 D $12.42 $33,054 D/D (2,555) 345,424     -
   Dowden Nathan J President & COO   •       –      –    2024-03-04 4 D $12.42 $9,728 D/D (752) 140,516     -
   Wentworth Kory James Chief Financial Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 30,900 80,471     -
   Sethuraman Natarajan Chief Scientific Officer   •       –      –    2024-03-01 4 A $0.00 $0 D/D 44,100 211,298     -
   Doshi Dipal CEO   •       •      –    2024-03-01 4 A $0.00 $0 D/D 104,700 347,979     -
   Dowden Nathan J President & COO   •       –      –    2024-03-01 4 A $0.00 $0 D/D 93,100 141,268     -
   Doshi Dipal CEO   •       •      –    2024-02-15 4 AS $15.00 $15,000 D/D (1,000) 243,279     -
   Doshi Dipal CEO   •       •      –    2024-01-16 4 AS $15.99 $15,990 D/D (1,000) 244,279     -
  213 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us